Galderma, a prescription skin treatment business under the umbrella of the L'Oreal and Nestle companies in Europe, is releasing a Botox competitor called Azzalure. According to a Bloomberg report, it is expected to contribute to cutting Botox's international market share by 4%.
The article is a bit misleading because it ignores the fact that Azzalure is actually the exact same product as Dysport, which is already being sold in Europe with Ipsen. It just packaged as a different product.
Dr. David Goldberg
Skin Laser Surgery Specialists of NY/NJ
Sanctuary Medical Aesthetic Center
Dr. Jason Pozner
Sanctuary Medical Aesthetic Center
Sanctuary Plastic Surgery
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment